指南与共识乳腺MR

COVID-19疫苗接种后乳腺MRI检出腋窝淋巴结病的结局与随访建议

Axillary adenopathy detected on breast MRI following COVID-19 vaccination: outcomes and follow-up recommendations.
指南 / 共识 · Clin Imaging · 2022-10-08

本研究回顾性分析110例乳腺MRI疑似COVID-19疫苗相关腋窝淋巴结病的患者,评估其结局。接种至MRI的中位时间在检出淋巴结病组更短(6周 vs 15周,p<0.001)。单侧腋窝淋巴结病恶性率低(3.3%),且无已知同侧乳腺癌时未诊断恶性腋窝淋巴结病。建议近期接种同侧单侧腋窝淋巴结病且无可疑乳腺发现或已知乳腺癌时可视为良性;但无论接种状态和时机,已知恶性肿瘤或可疑乳腺发现时单侧腋窝淋巴结病应视为可疑。

要点

  • 近期同侧COVID-19疫苗接种后单侧腋窝淋巴结病,无可疑乳腺发现或已知乳腺癌时可考虑良性。
  • 已知恶性肿瘤或可疑乳腺发现时,无论疫苗接种状态和时机,单侧腋窝淋巴结病应视为可疑。
  • 遵循此建议可避免不必要的预约限制、患者焦虑和费用,且不延误转移性乳腺癌诊断。

关键影像表现/征象

  • 乳腺MRI检出疑似COVID-19疫苗相关腋窝淋巴结病。
  • 接种至乳腺MRI的中位时间在检出淋巴结病患者中更短(6周[2-17] vs 15[7-24]周,p<0.001)。

诊断标准与关键数值

  • 单侧腋窝淋巴结病恶性率为3.3%。
  • 无已知同侧乳腺癌时未诊断恶性腋窝淋巴结病。

临床应用与阅片要点

  • 近期同侧疫苗接种后单侧腋窝淋巴结病,无可疑乳腺发现或已知乳腺癌时可考虑良性。
  • 已知恶性肿瘤或可疑乳腺发现时,单侧腋窝淋巴结病应视为可疑,避免延误诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

This retrospective study presents 110 patients with suspected COVID-19 vaccine-related axillary adenopathy on breast MRI. Our study aimed to assess the outcomes of axillary adenopathy detected on breast MRI performed within one year after COVID-19 vaccination. The median time between the COVID-19 vaccine and breast MRI was shorter in patients with detected adenopathy compared to patients without detected adenopathy (6 weeks [2-17] versus 15 [7-24] weeks, p < 0.001). Unilateral axillary adenopathy detected on breast MRI had a low malignancy rate (3.3%), and no cases of malignant axillary adenopathy were diagnosed without a known breast cancer in the ipsilateral breast. Our findings suggest that unilateral axillary adenopathy identified on breast MRI ipsilateral to a recent COVID-19 vaccination can be considered benign in the absence of a suspicious breast finding or known breast cancer. Regardless of vaccine status and timing, unilateral axillary adenopathy detected on MRI evaluation with a known malignancy or suspicious breast finding should be considered suspicious. This will avoid unnecessary scheduling constraints, patient anxiety, and cost, without delaying diagnosis of metastatic breast cancer.

来源:Clin Imaging,查看原文。版权归原作者所有。

引用

  1. Nguyen, Chen, Kwak, et al. Axillary adenopathy detected on breast MRI following COVID-19 vaccination: outcomes and follow-up recommendations. Clin Imaging. 2022. PMID: 36335676. doi:10.1016/j.clinimag.2022.10.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。